India · Delayed Price · Currency is INR Intra-Cellular Therapies Statistics
Total Valuation
BOM:500109 has a market cap or net worth of INR 220.04 billion. The enterprise value is 351.16 billion.
| Market Cap | 220.04B |
| Enterprise Value | 351.16B |
Important Dates
The last earnings date was Friday, July 18, 2025.
| Earnings Date | Jul 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:500109 has 1.75 billion shares outstanding. The number of shares has increased by 0.09% in one year.
| Current Share Class | 1.75B |
| Shares Outstanding | 1.75B |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 1.97% |
| Float | 178.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 13.30 |
| PS Ratio | 0.25 |
| PB Ratio | 1.70 |
| P/TBV Ratio | 1.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -124.82 |
| EV / Sales | 0.40 |
| EV / EBITDA | 18.44 |
| EV / EBIT | 66.62 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.01 |
| Debt / EBITDA | 7.01 |
| Debt / FCF | n/a |
| Interest Coverage | 0.47 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 1.20% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 350.95M |
| Profits Per Employee | -1.11M |
| Employee Count | 2,530 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.03B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.41% in the last 52 weeks. The beta is 0.30, so BOM:500109's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -38.41% |
| 50-Day Moving Average | 140.16 |
| 200-Day Moving Average | 137.79 |
| Relative Strength Index (RSI) | 37.98 |
| Average Volume (20 Days) | 343,205 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:500109 had revenue of INR 887.91 billion and -2.81 billion in losses. Loss per share was -1.61.
| Revenue | 887.91B |
| Gross Profit | 50.69B |
| Operating Income | 4.99B |
| Pretax Income | -3.85B |
| Net Income | -2.81B |
| EBITDA | 18.76B |
| EBIT | 4.99B |
| Loss Per Share | -1.61 |
Balance Sheet
The company has 313.90 million in cash and 131.43 billion in debt, giving a net cash position of -131.12 billion or -74.81 per share.
| Cash & Cash Equivalents | 313.90M |
| Total Debt | 131.43B |
| Net Cash | -131.12B |
| Net Cash Per Share | -74.81 |
| Equity (Book Value) | 129.70B |
| Book Value Per Share | 74.00 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 5.71%, with operating and profit margins of 0.56% and -0.32%.
| Gross Margin | 5.71% |
| Operating Margin | 0.56% |
| Pretax Margin | -0.43% |
| Profit Margin | -0.32% |
| EBITDA Margin | 2.11% |
| EBIT Margin | 0.56% |
| FCF Margin | n/a |
Dividends & Yields
BOM:500109 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.09% |
| Shareholder Yield | n/a |
| Earnings Yield | -1.28% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |